Role of Regional Anesthesia in Patients with Acute Sickle Cell Pain: A
Scoping Review
- Munaza Batool Rizvi,
- David O. Kessler,
- Joni E. Rabiner
David O. Kessler
Columbia University Irving Medical Center
Author ProfileJoni E. Rabiner
Columbia University Irving Medical Center
Author ProfileAbstract
Sickle cell disease is the most prevalent inherited blood disorder in
the world, with significant morbidity and mortality. Patients often have
recurrent painful vaso-occlusive episodes, and the American Society of
Hematology gives a conditional recommendation for the use of regional
anesthesia for acute sickle cell pain management. This scoping review
summarizes the current evidence and identifies gaps for future research.
Our screening process is outlined, and articles that mentioned the use
of regional anesthesia for acute sickle cell crises were included. We
present and interpret our results and highlight opportunities for future
investigation.23 Aug 2022Submitted to Pediatric Blood & Cancer 23 Aug 2022Submission Checks Completed
23 Aug 2022Assigned to Editor
29 Aug 2022Reviewer(s) Assigned
16 Sep 2022Review(s) Completed, Editorial Evaluation Pending
17 Sep 2022Editorial Decision: Revise Minor
23 Sep 2022Submission Checks Completed
23 Sep 2022Assigned to Editor
23 Sep 20221st Revision Received
25 Sep 2022Review(s) Completed, Editorial Evaluation Pending
25 Sep 2022Editorial Decision: Accept